We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Generic Makers Fear Weakening Of Hatch-Waxman Rules

Law360 (July 27, 2005, 12:00 AM EDT) -- U.S. generic drug makers are wary of plans to reform the U.S. patent system, fearing that the powerful brand-name drug lobby will use the process to water down landmark legislation that paved the way for the generic pharmaceuticals industry.

The industry fears that some provisions in the bill – especially a change in the standards for inequitable conduct during the patent application process – could fundamentally alter the rules of the game to give the upper hand to drug originators in patent litigation.

“What might appear...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.